NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 239 filers reported holding NEKTAR THERAPEUTICS in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $279,000 | +17.2% | 20,657 | +56.1% | 0.03% | +6.2% |
Q3 2021 | $238,000 | -65.5% | 13,231 | -67.1% | 0.03% | -65.2% |
Q2 2021 | $689,000 | -14.9% | 40,156 | -0.9% | 0.09% | -18.6% |
Q1 2021 | $810,000 | +27.8% | 40,506 | +8.6% | 0.11% | +18.9% |
Q4 2020 | $634,000 | +3.1% | 37,306 | +0.7% | 0.10% | -6.9% |
Q3 2020 | $615,000 | -26.7% | 37,056 | +2.3% | 0.10% | -31.5% |
Q2 2020 | $839,000 | +57.7% | 36,231 | +21.7% | 0.15% | +33.0% |
Q1 2020 | $532,000 | +25.8% | 29,781 | +51.9% | 0.11% | +62.3% |
Q4 2019 | $423,000 | – | 19,600 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
CM Management, LLC | 50,000 | $160,000 | 0.18% |
TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |